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De novo spinal glioblastomamultiforme (GBM) is a rare lesion of the
central nervous system with a poor prognosis. It represents about 1 to
3% of all spinal cord tumours [1]. In N60%of cases Spinal GBMdeveloped
at the cervical or cardiothoracic region. [2]. Patients with these rare le-
sionsmay presentwith symptoms similar tomore commonneurosurgi-
cal conditions [3]. Leptomeningeal gliomatosis (LM) refer to the spread
of malignant cells through the CSF space. High-grade glioma is themost
common tumor to lead to LM in adults. Currently the incidence of LM
can only be estimated [4]. Clinical presentation is varied, butmost com-
monly includes headache, nausea and vomiting, back pain or radicular
limb pain or sensory abnormalities and focal neurological deﬁcits. Prog-
nosis of LM is varying according to age and tumor type, is generally poor
even with aggressive treatment [4,5].
Information regarding primary spinal GBM to understand this rare
entity to guide the treatment is needed.We present a rare case of spinal
GBMwith leptomeningeal gliomatosis involving the Brainstem in a 39-
year-old female.2. Case report
A right-handed 39-year-old female was referred to our clinic for fur-
ther clariﬁcation after diagnosis of subarachnoid hemorrhage (SAH) in
the neurological department.
Initial symptoms were severe persistent pain in the neck and head-
ache in the posterior side of the head for one week accompanied with
nausea and vomiting. Medical history was non-contributory. Lumbar
puncture was done in the neurological department before referral
with 3 CSF-tubes with xanthochromic CSF. At admission in our clinic
no neurological deﬁcits were present.
At the admission, cerebral angiography, CT scan andMRI of the brain
have been performed.nt, Bonifatius hospital, lingen,
. Elsharkawy).
. This is an open access article underNo abnormality has been detected except for not requiring therapy
Isolate small developmental venous anomaly (DVA li.-frontal), other-
wise unremarkable brain parenchyma.
Three days later, a newMRI 3-Tesla scan of the brain and total neural
axis has been performed due to the worsen of the pain despite central
analgesics, which demonstrated an unclear lesion intraspinal intradural
with contrast enhancement in the level C4/5 ventro-lateral, T2/3 dorso-
lateral, L1/2 and L3with diffuse leptomeningeal contrast until brainstem
(pons) Fig. 1. Ophthalmological examination was normal.
Differential diagnoses were a granulomatous disease, neurosarcoidosis,
tuberculosis, inﬂammatory process, lymphoma, or leptomeningeal carcino-
matosis fromanoccultmalignancy. Total body Scintigraphy, CSF diagnostic,
standard tuberculosis and neurosarcoidosis diagnostics have been done.
The only positive result was the protein in CSF which was 4467 mg/L. m.
The number of cells was normal; no CSF cytological examination has
been done. One week later the patient showed paralysis of the 6th cra-
nial Nervewith deterioration of the orientation. A 3-TeslaMRI brain and
total neural axis was performed again, it revealed extension of the pre-
viously described lesion especially in brain stem area, medulla
oblongata and pons, no vertebral body enhancement or metastasis has
been detected. An open Biopsy was done after laminectomy T2. Histo-
pathology showed GBMwithmeningeal affection. The clinical situation
had been dramatic worsened with blindness and paralysis in upper
limb both side. Adjuvant therapy has been refused from the family
due to sever disability and blindness. The patient died after 35 day
from admission and 9 days after biopsy.
Histological examination: The tumor tissue showed all features of a
glioblastoma with predominantly small tumor cells, endothelial prolif-
eration, frequent mitotic ﬁgures and tumor necrosis. The tumor cells
reacted positively with antibodies against GFAP, CD56, S100, and
MAP2a, whereas EMA, IDH1, CD3, CD79a, CD99, AE1/AE3, MNF116,
MelanA, Synaptophysin and TTF1 were not expressed. The tumor
showed a high proliferation rate of 60% Ki67 positive cells Fig. 2.3. Discussion
Spinal glioblastoma multiforme (GBM) is a rare clinical entity espe-
cially in adults. It accounts about 1–5% of all glioblastoma and about 1 tothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A:MRI axial T2-weighted image at level C4 showing an intraparenchymal lesion withmeningeal affection, B: T2 post-contrast axial T2-weighted image at level C4 showing a week
enhancement with intradural intraparenchymal lesion and leptomeningeal enhancement. C: MRT sagittal T1-weighted image of the lumbar and thoracic region showed showing an
intraparenchymal location at level C4 level, D: MRT of brain showing the leptomeningeal enhancement up to Brainstem.
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ples cited in a limited number of case reports [1,4].
Clinically our case reports exhibit points of interest regarding the
site, clinical presentation, clinical course and radiological ﬁnding.
Regarding the site, our case showed lesions in cervical, thoracic and
lumbar region. Published data showed that in N60% of cases Spinal GBM
developed at the cervical or cervicothoracic region [2]. Spinal GBM is
rarely in 3 regions in the same time.
Regarding to clinical presentation, our case presented with typical
symptoms of SAH which laboratory conﬁrmed. However patients with
these rare lesions usually present with symptoms similar to more
commonneurosurgical conditions related to the site of the tumor [3]. Re-
garding the clinical course and radiological ﬁnding, our case showed at
the time of diagnosis multiple foci of glioblastoma with Leptomeningeal
gliomatosis seeding of a spinal cord to the brain, which usually appears
late in the course of disease. It is rare form of spinal GBM.
The Leptomeningeal gliomatosis explain the initial symptoms of
SAH in our case reported. In agreement with published data which
showed that clinical presentation in case of LM is most commonly in-
cludes headache, nausea and vomiting, back pain or radicular limb
pain or sensory abnormalities and focal neurological deﬁcits.
The fatal outcome in our case with ﬁve weeks duration is in agree-
ment with published data which showed that leptomeningealmetastases with CSF tumor dissemination almost always leading to a
fatal outcome, most patients with lesions in the cervical or upper tho-
racic cord have signiﬁcantly shorter survival [1,5].
Treatment of spinal GBM includes debunking of tumor and post-
operative radiation with/without chemotherapy. Surgical management
of an intramedullary mass consisted of biopsy, or cyst aspirationwith de-
compressive laminectomy. Radical surgical removal in patients with
intramedullary glioblastoma is impossible because there is not a clear
cleavage plane between the glioblastoma and themedullary parenchyma.
The value of radiotherapy and chemotherapy in spinal cord GBM
is a matter of debate due to the small number of cases reported in lit-
erature. However chemotherapy followed with radiotherapy is the
most commonly used treatment modality in case of leptomeningeal
metastasis [1,5]. Until now there is still no satisfactory treatment
for spinal GBM and leptomeningeal metastasis. Limited data exist
in literature to guide treatment.4. Conclusion
Primary spinal GBM is an extremely rare entity with a poor prognosis
and a short survival time. Improvements of current modes of treatment
are required to improve survival and ensure better quality of life. Our
Fig. 2. A: The picture shows a malignant small cell tumor with necrosis on the left side and pathological vessels on the right side of the picture (HE, ×200 original magniﬁcation). B:
malignant small cell tumor with two mitotic ﬁgures in the center of the picture is seen (HE, ×200 original magniﬁcation). C: positive Anti-GFAP reaction underlines the astrocytic line
of differentiation (Anti-GFAP, ABC, ×200 original magniﬁcation). D: The tumor proliferates highly (Anti-Ki67, ABC, ×200 original magniﬁcation).
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of the differential diagnosis of SAH with brain negative angiography.
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